Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study
Laura Dormer, Co-Founder and Editorial Director at Becaris Publishing, shared on LinkedIn about a recent article by Benoit Polack et al, adding:
”New Research Article published in the Journal of Comparative Effectiveness Research
‘Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study’
Using the French national healthcare claims database, the FORvWARD study examines treatment patterns, healthcare resource use and associated costs among adults with von Willebrand disease using on-demand replacement therapies.
This real-world analysis offers valuable insight into resource use in a rare bleeding disorder and highlights the role of national claims data in comparative treatment evaluation.”
Title: Real-word evidence on healthcare resource use and associated costs in on-demand users of replacement therapies in von Willebrand disease in France: the FORvWARD study
Authors: Benoit Polack, Virginie Nerich, Claire Marant Micallef, Marc Trossaërt, Christine Biron-Andreani, Nadège Bornier, Catherine Chatelanaz, Franck Favre-Besse, Julien Beoletto, Mélanie Née, Manon Belhassen, Cinira Lefèvre, Gérard de Pouvourville
Read the Full Article on Journal of Comparative Effectiveness Research

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026